Pacific Biosciences
PACB
80 hedge funds and large institutions have $197M invested in Pacific Biosciences in 2013 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 36 increasing their positions, 27 reducing their positions, and 12 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 27
7% more capital invested
Capital invested by funds: $184M → $197M (+$13.1M)
5% less call options, than puts
Call options by funds: $223K | Put options by funds: $234K
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
1% less funds holding
Funds holding: 81 → 80 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$8.36M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$6.51M |
| 3 |
MC
Maverick Capital
Dallas,
Texas
|
+$2.96M |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$2.82M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$2.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$8.71M |
| 2 |
DM
Deerfield Management
New York
|
-$2.45M |
| 3 |
Renaissance Technologies
New York
|
-$1.55M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$1.12M |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$967K |
PACB Hedge Fund Activity: Q4 2013 in Review
80 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Pacific Biosciences (PACB) for Q4 2013, worth a combined $197M — up 7.2% from $184M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of PACB and 11 opened new positions — a net loss of 1 holder — while 27 trimmed existing stakes and 36 added.
The largest buyer was BlackRock Institutional Trust, adding an estimated $8.36M. The largest seller was Redmile Group, exiting entirely with an estimated $8.71M sold.
- 80 institutional investors held Pacific Biosciences (PACB) as of Q4 2013, down from 81 in Q3 2013.
- Funds reported $197M of Pacific Biosciences stock for Q4 2013, up 7.2% quarter-over-quarter.
- 11 funds opened new Pacific Biosciences positions in Q4 2013 and 12 closed out, a net change of -1 holder.
- The largest Pacific Biosciences buyer in Q4 2013 was BlackRock Institutional Trust, an estimated $8.36M added.
- The largest Pacific Biosciences seller in Q4 2013 was Redmile Group, an estimated $8.71M sold.
Based on aggregated 13F filings for Q4 2013.